Siemens Highlights Oncology, Molecular Imaging Offerings at ASTRO

September 22, 2008 – Siemens Healthcare is showcasing the Treago Robotic Table, designed for fast, precise patient positioning during radiation therapy, at ASTRO 2008.

The Treago is said to fully automate the entire positioning process, increasing accuracy, saving patient on-table time, and supporting complex treatment applications and provides clinicians the flexibility to personalize patient care.

Siemens is also highlighting its two new treatment planning approaches, IM-RealART Solution and IM-Confident Plan, PreScision Stereotactic Solution, and kVision Kilovoltage Cone Beam Imaging.

IM-Confident Plan, says Siemens, is a simple, and efficient IMRT solution designed to deliver fast, high-quality IMRT treatments. It combines 160 MLC Multileaf Collimator with PROWESS Panther IMRT planning system to provide better tumor conformity and can reduce treatment time to less than five minutes – speeding up treatment delivery and improving treatment plan quality.

Designed specifically for immediate replanning within IGRT, the IM-RealART Solution combines the Treago Robotic Table with CTVision System and PROWESS RealART treatment planning system, to offer diagnostic-quality, in-room imaging, while providing the ability to replan the treatment on the spot and react immediately prior to treatment to changes in patient anatomy.

Siemens’ HD•PET, is reportedly the world’s first and only high-definition PET technology to offer consistently sharper and clearly defined images across the entire field of view. On display is the Biograph TruePoint PET•CT, featuring high resolution PET•CT for staging and planning, integration of biology imaging in the treatment plan with proven connectivity with most treatment plans.

The company will also display one of its latest applications to oncology workflow management, syngo TrueD, which enhances the ability to compare patient scans over time, by allowing the user to simultaneously display three studies, such as baseline and two follow-up exams. syngo TrueD was designed for the oncology workflow, including diagnosis, staging and assessment of cancer treatment response, and reportedly enables efficient reading of patient scans from hybrid imaging systems, such as PET•CT and SPECT•CT.


Treago Robotic Table, IM-RealART Solution and kVision are works in progress and not commercially available in the U.S.
PreScision Stereotactic Solution is pending 510(k) review and is not yet commercially available in the U.S.

For more information: http://www.siemens.com/healthcare.